Chemical Stimulation Of Growth Or Activity By Addition Of Chemical Compound Which Is Not An Essential Growth Factor; Stimulation Of Growth By Removal Of A Chemical Compound Patents (Class 435/244)
  • Publication number: 20090324778
    Abstract: The present invention relates to the preparation of a 5?-phosphodiesterase extracted from sorghum, and to its use for the preparation of a composition rich in 5?-nucleotides, in particular of a yeast extract.
    Type: Application
    Filed: September 11, 2007
    Publication date: December 31, 2009
    Applicant: LESAFFRE ET COMPAGNIE
    Inventors: Eric Oriol, Nadia Kaid
  • Publication number: 20090317892
    Abstract: A dead cell of a lactic acid bacterium or a culture containing the dead cell of a lactic acid bacterium is added to the dairy products such as yogurt, cheese, milk beverage or the like in an amount of 0.001 wt % or more in dry weight of the dead cell, therefore, it is possible to enhance the growth of a lactic acid bacterium, to shorten the time required for fermentation, and to improve the viability of a lactic acid bacterium during storage over a long period, without affecting the flavor or production cost of the dairy product.
    Type: Application
    Filed: June 26, 2007
    Publication date: December 24, 2009
    Applicant: SNOW BRAND MILK PRODUCTS CO., LTD.
    Inventors: Mari Miura, Yasuyaki Seto, Masayuki Watanabe, Toshimitsu Yoshioka
  • Publication number: 20090304749
    Abstract: The present invention relates to a method of producing rough strains of a bacterium, such as Mycobacterium obuense, said method comprising exposing said bacterium to a sulfone and/or sulfonamide (such as 4,4?-Diaminodiphenyl sulfone or an analogue thereof). A rough strain of Mycobacterium obuense producible by said method and uses thereof. In particular, uses of a rough strain of Mycobacterium obuense deposited under the Budapest Treaty of NCTC with the accession number NCTC 13365.
    Type: Application
    Filed: December 19, 2006
    Publication date: December 10, 2009
    Applicant: BIOEOS LIMITED
    Inventors: John Lawson Stanford, Cynthia Ann Stanford, Graham McIntyre, Oscar Adelmo Bottasso
  • Publication number: 20090291484
    Abstract: A simple solid phase extraction (SPE) method for continuous sequestering and concentration of waterborne cues from sea water conditioned with aquatic source organisms that induce toxin formation in dinoflagellates, and a method of increasing this toxin formation.
    Type: Application
    Filed: May 23, 2008
    Publication date: November 26, 2009
    Inventors: Erik Selander, Henrik Pavia
  • Patent number: 7611885
    Abstract: The present invention provides a method for purifying bacterial minicells that involves subjecting a sample containing minicells to density gradient centrifugation in a biologically compatible medium. The method optionally includes a preliminary differential centrifugation step and one or more filtration steps. The invention also provides a method for purifying bacterial minicells in which a sample containing minicells is subjected to a condition that induces parent bacterial cells to adopt a filamentous form, followed by filtration of the sample to separate minicells from parent bacterial cells. The inventive methods optionally include one or more steps to remove endotoxin from purified minicell preparations, and/or treatment of purified minicell preparations with an antibiotic. Additionally, the invention provides purified minicell preparations, prepared according to the foregoing methods, and containing fewer than about 1 contaminating parent bacterial cell per 107, 108, 109, 1010, or 1011 minicells.
    Type: Grant
    Filed: June 24, 2003
    Date of Patent: November 3, 2009
    Assignee: Engeneic Molecular Delivery Pty, Ltd.
    Inventors: Himanshu Brahmbhatt, Jennifer MacDiarmid
  • Patent number: 7604978
    Abstract: The present invention relates to compositions and methods for reducing or inhibiting biofilm comprising modulating expression of a cysB gene in a cell. The invention also provides methods for modulating the expression of a cysB, cysD, cysI, cysJ, cysK, and ybiK. The invention further provides methods for identifying gene(s) involved in biofilm formation and for identifying biofilm inhibitors.
    Type: Grant
    Filed: March 21, 2005
    Date of Patent: October 20, 2009
    Assignee: Sequoia Sciences, Inc.
    Inventor: Gary R. Eldridge
  • Publication number: 20090258015
    Abstract: The invention relates to modulation of fungal morphology between yeast-to-hyphal growth transition by controlling muramyl-L-alanine concentration and uses thereof.
    Type: Application
    Filed: August 21, 2007
    Publication date: October 15, 2009
    Inventors: Yue Wang, Xiao-Li Xu, Raymond Teck Ho Lee
  • Publication number: 20090246177
    Abstract: This invention relates to a novel strain of Megasphaera elsdenii and its uses. This invention further relates to preparations and methods incorporating such strain. This invention also relates to feedstuffs for ruminants and a preparation and method for the prevention and treatment of lactic acidosis in ruminants. This invention even further relates to a method of isolating a biologically pure culture of a superior ruminal microorganism in a relatively shorter time period than conventional methods. This invention yet further relates to a method of achieving any one or more of the following improvements in ruminants namely increased milk production; improved feedlot performance; improved growth rate; decrease in finishing time; lower digestive morbidity and mortality; lower incidence of lactic acidosis and related diseases; improved feed conversion efficiency; decrease in roughage content in feeds; and capability to feed on relatively higher concentrate diets.
    Type: Application
    Filed: November 30, 2008
    Publication date: October 1, 2009
    Applicants: AGRICULTURAL RESEARCH COUNCIL, YARA PHOSPHATES OY
    Inventors: Charles Henry HORN, Albrecht Kistner, Barend Jacobus Greyling, Alexandra Helena Smith
  • Publication number: 20090233340
    Abstract: A process for the use of low concentration levels of Erythromycin to eliminate or control the growth of unwanted or undesirable bacteria (contaminating bacteria) in the fermentation production of alcohols without inhibition of the growth or replication of the yeast.
    Type: Application
    Filed: March 13, 2008
    Publication date: September 17, 2009
    Inventors: Kevin E. Dailey, Kevin L. Kauers
  • Publication number: 20090227001
    Abstract: The present invention provides a composition of Antrodia cinnamomea, a mixture of Antrodia cinnamomea, a fungal mixture and preparation thereof. In particular, the present invention can massively produce fungi in gel mediums.
    Type: Application
    Filed: June 18, 2008
    Publication date: September 10, 2009
    Applicant: COJET BIOTECH INC.
    Inventors: Yu-Lung Wang, Shu-Chun Chung
  • Publication number: 20090221026
    Abstract: To provide a microorganism capable of producing a large amount of carotenoids, mainly astaxanthin, and to provide a method of producing carotenoids using the microorganism, a microorganism having improved carotenoid productivity is used, which is obtainable by breeding a carotenoid producing Paracoccus bacteria which is featured by producing 720 mg or more carotenoid per 1 L of culture medium. Also used is a method of producing carotenoids using the bacterium.
    Type: Application
    Filed: September 26, 2006
    Publication date: September 3, 2009
    Applicant: TOSOH CORPORATION
    Inventors: Toru Tanaka, Teruhiko Ide, Kei-ichi Murayama, Seigou Oe, Toru Imaizumi, Satoshi Hanzawa, Toshinobu Toyoshima
  • Patent number: 7566528
    Abstract: An in vivo method for the identification and/or validation of receptor tyrosine kinase inhibitors is described. Said method is characterized by the following steps: providing host cells comprising a nucleic acid construct encoding a peptide which comprises a tyrosine kinase domain of a receptor tyrosine kinase wherein said peptide lacks a transmembrane domain or a functional fragment thereof and said tyrosine kinase activity in the cytoplasma leads to proliferation arrest, contacting said host cells with a candidate compound and identification of inhibitors of said tyrosine kinase activity by cultivation of said host cells under suitable conditions such that the modulation of the tyrosine kinase activity by the candidate compound leads to cell growth.
    Type: Grant
    Filed: April 22, 2005
    Date of Patent: July 28, 2009
    Assignee: Esbatech AG
    Inventors: Tea Gunde, Catherine Berset, Alcide Barberis
  • Patent number: 7560264
    Abstract: Disclosed is a method for promoting auto-induction of transcription of cloned DNA in cultures of bacterial cells grown batchwise, the transcription being under the control of a promoter whose activity can be induced by an exogenous inducer whose ability to induce said promoter is dependent on the metabolic state of said bacterial cells. Initially, a culture media is provided which includes: i) an inducer that causes induction of transcription from said promoter in said bacterial cells; and ii) a metabolite that prevents induction by said inducer, the concentration of said metabolite being adjusted so as to substantially preclude induction by said inducer in the early stages of growth of the bacterial culture, but such that said metabolite is depleted to a level that allows induction by said inducer at a later stage of growth. The culture medium is inoculated with a bacterial inoculum, the inoculum comprising bacterial cells containing cloned DNA, the transcription of which is induced by said inducer.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: July 14, 2009
    Assignee: Brookhaven Science Associates, LLC
    Inventor: F. William Studier
  • Patent number: 7556929
    Abstract: Methods and kits for identifying novel anti-tumor agents are provided.
    Type: Grant
    Filed: April 3, 2006
    Date of Patent: July 7, 2009
    Assignee: Tufts University
    Inventor: Dean Dawson
  • Publication number: 20090170184
    Abstract: The system for fermentation using algae of the present invention includes a first reactor and a second reactor being in fluid communication with each other. A first valve placed between the first reactor and the second reactor controls the fluid connection between the reactors. A gas inlet, in fluid connection to the first reactor, is located at an end opposite the second reactor. A devolatization unit or cell lysis chamber is connected to the second reactor by a second valve. A biomass stream having gas, liquid and biosolids contents passes through the first reactor with gas. The biomass stream mixes and dissolves the gas in the reactors. The cellular structure of the biomass stream ruptures in the devolatization unit, allowing the processed materials, such as oil, gas, and biosolids, to be harvested for use.
    Type: Application
    Filed: May 5, 2008
    Publication date: July 2, 2009
    Applicant: Missing Link Technologies, L.L.C.
    Inventors: Samuel L. SHEPHERD, Jerry McCall
  • Patent number: 7547536
    Abstract: A method of detecting the presence and quantity of bacterial spores, which includes adding an electrophilic alcohol and an acid anhydride to a sample, admixing the sample with a solvent, and analyzing the sample. The sample may be analyzed by injecting the mixture into a gas chromatograph equipped with a mass spectra detector.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: June 16, 2009
    Assignee: JEOL USA, Inc.
    Inventors: James A. Laramée, Robert B. Cody
  • Publication number: 20090111156
    Abstract: Without using any pumps and controlling devices, to control microorganism's activity by supplying an activity controlling substance which is necessitated for the microorganism activity is realized. A microbial activity controlling material 3 is filled into a vessel 4 having a sealed structure and at least a part of which is provided with a non-porous film 2, and then, the microbial activity controlling material 3 is supplied through the non-porous film 2 part of the vessel 4 to ambient places around the vessel 4 at the speed controlled by the molecular permeation performance of the non-porous film 2, and thereby the activities of microorganisms residing around the vessel is controlled.
    Type: Application
    Filed: June 15, 2006
    Publication date: April 30, 2009
    Inventors: Hiroaki Uemoto, Masahiko Morita, Atsushi Watanabe
  • Patent number: 7501278
    Abstract: A device for measuring an extracellular potential of a test cell includes a substrate having a well formed in a first surface thereof and a first trap hole formed therein. The well has a bottom. The first trap hole includes a first opening formed in the bottom of the well and extending toward a second face of the substrate, a first hollow section communicating with the first opening via a first connecting portion, and a second opening extending reaching the second surface and communicating with the first hollow section via a second connecting portion. The first connecting portion has a diameter smaller than a maximum diameter of the first hollow section, greater than a diameter of the second connecting portion, and smaller than a diameter of the test cell. The device can retain the test cell securely and accept chemicals and the test cell to be put into the device easily.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: March 10, 2009
    Assignee: Panasonic Corporation
    Inventors: Masaya Nakatani, Hiroaki Oka, Fumiaki Emoto
  • Publication number: 20090017074
    Abstract: The invention relates to a culture medium for Haemophilus influenzae type b, characterized in that the source of protein nitrogen is of non-animal origin and comprises at least one plant peptone and in that the heme source consists of protoporphyrin IX. This medium serves in particular for the production of polyribosyl phosphate (PRP) and for the manufacture of a vaccine against Haemophilus influenzae type b meningitis.
    Type: Application
    Filed: July 10, 2008
    Publication date: January 15, 2009
    Applicant: SANOFI PASTEUR SA
    Inventors: Ghislaine Maitre-Wilmotte, Denis Speck, Bachra Rokbi
  • Patent number: 7476529
    Abstract: Compositions of peptides and surface-active agents are described, as are methods of making and using such compositions. The compositions are capable of affecting metabolic rates in biological systems, and to accelerate nutrient uptake without a concomitant increase in biofilm production.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: January 13, 2009
    Assignee: Advanced BioCatalytics Corporation
    Inventors: Carl W. Podella, Nils Siegfried Hauptmann
  • Publication number: 20080318773
    Abstract: The identification of compounds, strigolactones, having the ability to stimulate the growth and/or development of arbuscular mycorrhizal fungi (AM fungi). Such compounds are, for example, the natural strigolactones strigol, alectrol, sorgolactone, orobanchol, or their synthetic analogs GR7, GR24, Nijmegen-1, demethylsorgolactone. New ways of developing an agriculture that is more respectful of the environment, and permits the implementation, on a small or large scale, of advanced mycorrhization techniques aimed at optimizing the production of fungic inoculum, the use of AM fungi in soils or cultivation substrates, and intensifying the symbiotic interaction between these microorganisms and cultivated plants.
    Type: Application
    Filed: February 9, 2005
    Publication date: December 25, 2008
    Inventors: Guillaume Becard, Christophe Roux, Nathalie Sejalon-Delmas, Virginie Puech, Sebastien Roy
  • Publication number: 20080312319
    Abstract: The present invention provides compounds and methods for modulation of the quorum sensing of bacteria. In an embodiment, the compounds of the present invention are able to act as replacements for naturally occurring bacterial quorum sensing ligands in a ligand-protein binding system; that is, they imitate the effect of natural ligands and produce an agonistic effect. In another embodiment, the compounds of the present invention are able to act in a manner which disturbs or inhibits the naturally occurring ligand-protein binding system in quorum sensing bacteria; that is, they produce an antagonistic effect. The compounds of the present invention comprise N-acylated-homoserine lactones (AHLs) comprised of a wide range of acyl groups.
    Type: Application
    Filed: March 19, 2008
    Publication date: December 18, 2008
    Inventors: Helen E. Blackwell, Grant D. Geske, Jennifer C. O'Neill
  • Patent number: 7452721
    Abstract: Methods for the diagnosis of visceral, cutaneous and canine leishmaniasis in a subject suspected of being infected with the parasitic protozoa Leishmania is disclosed. Disclosed are antibody-capture enzyme-linked immunosorbent assays (ELISAs) for the detection of antibodies to Leishmania parasite soluble antigens and antigen-capture ELISAs for the detection of Leishmania parasite soluble antigens in host samples. Also disclosed are immunodiagnostic kits for the detection of Leishmania parasite circulating antigens or IgM and IgG antibodies in a sample from subject having visceral, cutaneous or canine leishmaniasis. In these methods and kits, detection may be done photometrically or visually. The methods and kits also allow the visualization of Leishmania amastigotes or promastigotes in a sample.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: November 18, 2008
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Samuel K. Martin
  • Patent number: 7440160
    Abstract: The invention relates to electrooptical light modulating elements, to electrooptical displays containing elements of this type, and to display systems, e.g. television screens and computer monitors, and to the modulating media used therein. The inventive light modulating elements contain a mesogenic modulating medium that exists in an optically isotropic phase when the light modulating elements are in operation and, in addition to having a good contrast, a low dependency on the viewing angle and very short switching times, they are particularly characterized by having relatively low driving voltages with a very low dependency on temperature. The inventive modulating media are characterized in that they contain a chiral constituent. They preferably also contain an achiral constituent. Especially preferred, the control media comprise a blue phase.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: October 21, 2008
    Assignee: Merck Patent GmbH
    Inventors: Michael Heckmeier, Markus Czanta, Achim Goetz, Peer Kirsch, Louise Diane Farrand, Andreas Taugerbeck, Elvira Montenegro
  • Patent number: 7435578
    Abstract: A device and methods for monitoring status of at least one cell, wherein the cell has a membrane forming a substantially enclosed structure and defining an intracellular space therein. In one embodiment of the present invention, the device includes a first substrate having a first surface and an opposite second surface, a second substrate supported by the first substrate, the second substrate having a first surface, an opposite second surface, a body portion between the first surface and the second surface, a first side surface and an opposite second side surface, wherein the body portion defines a first passage between the first side surface and the second side surface and an opening on the first surface of the second substrate and in fluid communication with the first passage, and sidewalls positioned above the first surface of the second substrate.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: October 14, 2008
    Assignee: Vanderbilt University
    Inventors: John P. Wikswo, Franz J. Baudenbacher, Owen McGuinness
  • Publication number: 20080227178
    Abstract: A polypeptide factor derived from the thermophilic eubacterial species Thermus thermophilus has universal protein expression-assisting activity. The polypeptide factor has been named the CzrB protein active in fill length or truncated form has the potential to act as a universal protein expression-assisting molecule which can increase the yields of all heterologous proteins produced in E. coli by a mechanism that is independent of the protein being expressed.
    Type: Application
    Filed: November 23, 2007
    Publication date: September 18, 2008
    Inventors: Joseph Tony PEMBROKE, Stefanta Spada, John Gerard Wall
  • Publication number: 20080227177
    Abstract: This invention relates to an improved process for culturing bacteria of the family Streptococcaceae (such as of the genus lactococcus), a medium for culturing the bacteria, and the obtained bacteria cells.
    Type: Application
    Filed: June 16, 2006
    Publication date: September 18, 2008
    Inventors: Henrik Mollgaard, Henrik Romer, Asger Geppel
  • Publication number: 20080194003
    Abstract: A system including a harvested plant material degradation system, a microbial growth system in fluid contact with the harvested plant material degradation system, and an intermediary animal system in biomass-transfer interaction with the microbial growth system is disclosed. The intermediary animal can be fed to a product animal for consumption by the product animal. The intermediary animal can be worms, annelids, arthropods, mollusks, and/or fish. The intermediary animal can be provided for human consumption and/or consumption by a product animal, such as a crustacean, mollusk, fish, bird, pig, goat or cow. The product animal can be subsequently provided for human consumption. The harvested plant material degradation system can include polyculture plant material or photosynthetically produced material obtained from a single species of plant.
    Type: Application
    Filed: February 13, 2007
    Publication date: August 14, 2008
    Inventor: Jere Northrop
  • Publication number: 20080182295
    Abstract: A method of preparing a recombinant polypeptide of interest includes fermenting a host cell being transformed with a recombinant expression system capable of bringing about secretion of a polypeptide of interest into the periplasm of said host cell. The polypeptide of interest is extracted from the periplasm by applying a continuous osmotic shock to the host cells contained in a fermentation medium. An apparatus for osmotically shocking cells includes a first reservoir containing cells in a first solution and a second reservoir containing a second solution, the first solution having a higher osmolarity than the second solution. A method for osmotically shocking cells using the first and second solutions is also disclosed. Also disclosed is a method of isolating a recombinant polypeptide of interest from a cell.
    Type: Application
    Filed: January 11, 2008
    Publication date: July 31, 2008
    Inventors: Anant Y. Patkar, Subrata Sen, Micheal L. Chappell
  • Publication number: 20080176213
    Abstract: Provided is a method for controlling the degree of labeling (DOL) of a carrier molecule or solid support by the addition of a reactive label competitor to the labeling reaction. When the reactive label competitor is added to the labeling solution the competitor competes with the carrier molecule or solid support for the label, reducing the number of labels available to conjugates to the carrier molecule or solid support. This provides for a facile method that predictably alters the DOL of a carrier molecule or solid support.
    Type: Application
    Filed: March 27, 2008
    Publication date: July 24, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: John Matthew Mauro, Thomas Harry Steinberg, Lawrence I. Greenfield, Louis Leong
  • Patent number: 7396672
    Abstract: A method for selectively enhancing the growth of the population of a dinoflagellate comprises incubating a medium containing at least one dinoflagellate cell in the presence of mimosine or a toxic degradative product thereof is provided as well as isolates and cultures of dionoflagellates obtainable by said method. A method for isolating chemical compounds produced by dinoflagellates and chemical compounds obtainable by said method are also provided, as well as a method of identifying the causative agent of red tides.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: July 8, 2008
    Inventors: Tin Yum Joseph Wong, Ka Kit Yeung, To Wai Francis Wong
  • Publication number: 20080096265
    Abstract: A culture medium for filamentary fungi comprising at least one carbon source chosen from the group consisting of molasses, malt extract and sucrose a nd at least one organic nitrogen source chosen from yeast extract and corn steep liquor is described; a method for producing filamentary fungi, in particular nematophagus fungi on an industrial scale, comprising the step of seeding conidia of such fungi in the aforementioned culture medium and maintaining such a culture medium at a temperature of 23-30° C. for a time of 5-10 days to determine the reproduction and growth of the fungi is also described.
    Type: Application
    Filed: February 8, 2005
    Publication date: April 24, 2008
    Applicant: Urea Casale S.A.
    Inventor: Elisabeth Panchaud-Mirabel
  • Publication number: 20080020002
    Abstract: Methods for producing quadrivalent meningococcal meningitis polysaccharide and conjugate vaccines for serotypes A, C, Y and W-135 disclosed. Neisseria meningitidis fastidious medium was designed to maximize the yield of capsular polysaccharides and generate minimal cellular biomass and endotoxin in a short duration of fermentation. The crude polysaccharides are isolated, purified, and mechanically depolymerized by sonication. These purified polysaccharides were found in human clinical trials to be safe and immunogenic against meningococcal disease caused by N. meningitidis A, C, Y and W-135 serogroups in sub-Saharan Africa. In the preferred embodiment, the polysaccharides are conjugated to carrier proteins of diphtheria or tetanus toxiod to an average molecular size of 5100 to 9900 Daltons and provide broad spectrum protection to humans of all ages. Accelerated polysaccharide production and the efficacy of the resulting vaccine are demonstrated.
    Type: Application
    Filed: June 12, 2007
    Publication date: January 24, 2008
    Inventor: Jeeri R. Reddy
  • Patent number: 7319028
    Abstract: The present invention provides a process for efficiently producing sporangia of Bacillus popilliae containing spores and parasporal bodies having controlling effects on Scarabaeidae insects, and a control agent and controlling method for Scarabaeidae insects obtained by said production process. In a process for producing sporangia of Bacillus popilliae containing spores and parasporal bodies by culturing Bacillus popilliae in a medium containing an adsorbent, the medium contains 0.2-4.0% by weight of glutamic acid.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: January 15, 2008
    Assignees: Dainippon Ink and Chemicals, Inc., Chiba Prefectural Government
    Inventors: Gaku Ehara, Masaharu Kimura, Hideji Nishihashi, Tomoko Yokoyama, Makoto Hasegawa, Masao Tanaka, Azusa Fujiie, Shinichi Aoyagi
  • Patent number: 7279301
    Abstract: The present invention provides a method for determining an antioxidant deficiency in a lymphocyte by determining the level of intracellular cysteine in the lymphocyte by measuring lymphocyte growth in a serum-free cell culture medium comprising cumene hydroperoxide and N-acetyl-L-cysteine (NAC), whereby any antioxidant deficiency correlates with lymphocyte growth in such a cell culture medium.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: October 9, 2007
    Assignee: Research Development Foundation
    Inventor: J. Fred Crawford
  • Patent number: 7264951
    Abstract: This invention provides methods whereby taxol, baccatin III, and other taxol-like compounds, or taxanes, can be produced in very high yield from all known Taxus species, e.g., brevifolia, canadensis, cuspidata, baccata, globosa, floridana, wallichiana, media and chinensis. Particular modifications of culture conditions (i.e., media composition and operating modes) have been discovered to enhance the yield of various taxanes from cell culture of all species of Taxus. Particularly preferred enhancement agents include silver ion or complex, jasmonic acid (especially the methyl ester), auxin-related growth regulators, and inhibitors of the phenylpropanoid pathway, such as 3,4-methylenedioxy-6-nitrocinnamic acid. These enhancement agents may be used alone or in combination with one another or other yield-enhancing conditions. While the yield of taxanes from plant cell culture of T.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: September 4, 2007
    Assignee: Phyton, Inc.
    Inventors: Venkataraman Bringi, Prakash G. Kadkade, Christopher L. Prince, Braden L. Roach
  • Patent number: 7241589
    Abstract: The present invention relates to a method for preparation of androst-4-ene-3,17-dione (AD) and androsta-1,4-diene-3,17-dione (ADD). More particularly, the present invention relates to a method for preparing AD/ADD, comprising the steps of: (a) heating sterols and emulsifier respectively, to dissolve completely and mixing to prepare a mixture; (b) placing the mixture in a water bath at 70˜90° C. and stirring to obtain emulsified sterols; and (c) adding the emulsified sterols to culture media of microorganism as a component. And the present invention relates to a method for preparing AD/ADD, comprising the addition of cyclodextrin-sterol complexes extracted from milk to culture media of microorganism as a component. The emulsified sterols and cyclodextrin-sterol complexes adopted in the present invention can be easily prepared and be effectively used for obtaining AD/ADD at a high yield.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: July 10, 2007
    Assignee: Eugene Science Inc.
    Inventors: Seung-Kwon Noh, Myung-Kuk Kim, Won-Tae Yoon, Kyung-Moon Park, Sang-Ok Park
  • Patent number: 7179635
    Abstract: The present invention provides peptides libraries which are useful for rapid identification of biologically active compounds. The invention further provides peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins. Many of the peptides of the invention may be produced in large quantity by recombinant techniques and formulated in culture medium to produce the desired effect on cultured cells and tissues. Certain of the libraries of the invention and the peptides identified in them are particularly useful in concatemer-based recombinant expression methods.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: February 20, 2007
    Assignee: Becton, Dickinson and Company
    Inventors: Perry D. Haaland, Douglas B. Sherman, Robert L. Campbell, Walter William Stewart, Sheila A. Lloyd, Ann Hart Erickson, legal representative, Bruce Wayne Erickson, deceased
  • Patent number: 7166290
    Abstract: The present invention provides improved methods and compositions for producing oocysts. The oocysts produced according to the invention find use in the manufacture of vaccines. In preferred embodiments, the present invention provides methods and compositions for the production of Eimeria oocysts. Vaccines containing Eimeria oocysts, sporocysts and/or sporozoites produced according to the present invention may be used to immunize birds against coccidiosis either in ovo or post hatch.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: January 23, 2007
    Assignee: Embrex, inc.
    Inventors: James E. Hutchins, Julius K. Tyczkowski
  • Patent number: 7063969
    Abstract: The invention provides a method of synthesis of a substituted or unsubstituted carbinol compound, comprising the steps of subjecting the corresponding substituted or unsubstituted aromatic aldehyde to acyloin condensation mediated by yeast in the presence of either (a) a supereritical fluid or (b) a liquefied gas, and recovering the carbinol compound. Preferably the yeast is Saccharomyces cerevisiae. In a particularly preferred embodiment the aromatic aldehyde is benzaldehyde and the carbinol is phenylacetylcarbinol, according to the reaction (I): in which the benzaldehyde, the pyruvic acid, or both may optionally be substituted.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: June 20, 2006
    Assignees: Victoria University of Technology, Polychip Pharmaceuticals Pty, Ltd.
    Inventors: Andrew John Smallridge, Maurice Arthur Trewhella, Kylie Anne Wilkinson
  • Patent number: 7018813
    Abstract: Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: March 28, 2006
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Milan S. Blake, John A. Bogdan, Jr., Javier Nazario-Larrieu
  • Patent number: 7018838
    Abstract: The present invention relates to the field of molecular diagnostics, and in particular to diagnostics based on a liquid crystal assay format. In particular, the present invention provided improved substrates and methods of using liquid crystal assays for quantitating the amount of an analyte in a sample. The present invention also provides materials and methods for detecting non-specific binding of an analyte to a substrate by using a liquid crystal assay format.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: March 28, 2006
    Assignee: Platypus Technologies, LLC
    Inventors: Christopher Murphy, Barbara Israel, Nicholas Abbott
  • Patent number: 7011957
    Abstract: The method of the invention is directed to the novel use of a diffusion chamber within which previously “uncultivatible” microorganisms can be isolated. Rather than attempting to replicate the natural environment of an unknown microorganism, the method of the invention provides for exposing dividing microorganisms to all the components of the original environment while simultaneously containing the resulting colonies so that they can be isolated. The method of the invention can take advantage of the recognition that the preponderance of difficult-to-grow microorganisms do not form colonies visible to the naked eye. Therefore, these organisms must be isolated under a compound microscope as “microcolonies.” In addition, methods according to the invention permit the isolation of novel microorganisms capable of growing in artificial media only in co-culture in the presence of a companion microorganism.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: March 14, 2006
    Assignee: Northeastern University
    Inventors: Kim Lewis, Slava S. Epstein, Tammi Kaeberlein
  • Patent number: 7001758
    Abstract: A biodegradation process for the organophosphonate product of Sarin (O-isopropyl methylphosphonofluoridate) hydrolysis, i.e., isopropylmethylphosphonate (IMPA). This process provides a feasible biodegradation demilitarization alternative to Sarin incineration. Public opposition of nerve agent incineration is widespread, and alternative methods are sought to help the U.S. Army meet the 2007 demilitarization deadline imposed by the Chemical Weapons Convention. This process uses a two-step approach to IMPA biodegradation. In the first step, a concentrated IMPA solution is used as the sole nutritional carbon and phosphorus source for microbial cultures. The second step involves diluting the culture and adding an inexpensive carbon source to encourage bacterial phosphate assimilation. The biodegradation typically involves a consortium of microorganisms comprising Methylobacterium radiotolerans GB21, Agrobacterium tumefaciens GB2GA, Klebsiella oxytoca GB2CS, GB272, Aureobacterium sp.
    Type: Grant
    Filed: May 12, 2003
    Date of Patent: February 21, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Ilona J. Fry, Joseph J. DeFrank, James P. Earley
  • Patent number: 6991931
    Abstract: A method has been developed to maintain the health of an activated sludge environment in a wastewater process comprising monitoring the levels of polyhydroxyalkanoates (PHA) produced as an indicator of bioreactor health and regulating the concentration of feed nutrients and nitrate to maintain bioreactor health. In general, levels of PHA in excess of about 15% to about 20% dry weight of the biomass is an indication that the biocatalytic efficiency of the wastewater treatment process is impaired.
    Type: Grant
    Filed: January 21, 2004
    Date of Patent: January 31, 2006
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Dominic A. Dragotta, Vasantha Nagarajan, Stuart M. Thomas
  • Patent number: 6977166
    Abstract: C. cohnii is cultured in a suitable growth medium with acetic acid/acetate as the main carbon source. The acetate is provided, and replenished, by adding acetic acid to the growth medium in response to an increase in pH resulting from the utilisation of acetic acid/acetate by C. cohnii. The C. cohnii produces relatively high levels of docosahexaenoic acid (DHA). A stationary phase is not essential for satisfactory DHA production.
    Type: Grant
    Filed: July 13, 2000
    Date of Patent: December 20, 2005
    Assignees: The University of Hull, ATV BV
    Inventors: Colin Ratledge, Alistair James Anderson, Kanagasooriyam Kanagachandran, David John Grantham, Janet Christine Stephenson, Martin E. de Swaaf, Lolke Sijtsma
  • Patent number: 6955911
    Abstract: In cultivating a microorganism having nitrile hydratase production ability, by allowing at least one of a ketose, such as fructose, and a sugar alcohol, such as mannitol, to be present, growth inhibition by cobalt ion is prevented, thereby achieving cultivation at a high concentration and with a high activity.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: October 18, 2005
    Assignee: Mitsubishi Rayon Co., Ltd.
    Inventors: Koichiro Ryuno, Etsuko Kobayashi
  • Patent number: 6946277
    Abstract: This invention provides a method for enhancing the cellobiase activity of the strain Termitimyces clypeatus using 2-deoxy-D-glucose as glycosylation inhibitor, said process comprises inoculating and growing mycelial culture of (the edible mushroom) Termitimyces clypeatus, in sterilized medium containing 0.05 to 5.0% of 2-deoxy-D-glucose in addition to 0.5 to 2.0% of cellobiose, succinate—0.5%, 2 to 3% of ammonium di hydrogen phosphate and conventional micro-nutrients at pH between 3 to 8 and incubating at temperatures between 20-35° C. under shaking in aerobic conditions, and separating the culture medium by known methods, and using the culture filtrate directly as the source of the enzyme cellobiase and also for endo-glucanase and cellobiohydrolase for use in cellulose hydrolysis.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: September 20, 2005
    Assignee: Council of Scientific and Industrial Research
    Inventors: Suman Khowala, Sumana Mukherjee
  • Patent number: 6939705
    Abstract: A bacterial cell having protection against conditions which are lethal to an unprotected bacterial cell wherein, the protected cell is obtained by subjecting a bacterial cell to treatment with a sublethal level of stress.
    Type: Grant
    Filed: June 9, 2000
    Date of Patent: September 6, 2005
    Assignee: Nestec S.A.
    Inventors: Gudrun Schmidt, Ralf Zink
  • Patent number: 6919197
    Abstract: The subject invention provides novel and advantageous methods for growing bacteria. The methods of the subject invention are particularly advantageous for growing parasitic bacteria, in vitro, without the presence of host tissue. In one embodiment of the subject invention, Pasteuria spores, such as those that infect the rootknot nematode Meloidogyne arenaria or other host nematodes, are grown in vitro. The process of the subject invention is highly advantageous because Pasteuria can be grown in the absence of nematode tissue.
    Type: Grant
    Filed: January 20, 2004
    Date of Patent: July 19, 2005
    Assignee: Entomos, Inc.
    Inventors: John F. Gerber, James H. White